Key Highlights
- Macy’s shares touched a 52-week peak of $25.67, posting gains of approximately 1.84% in the session
- TD Cowen boosted its price objective to $25 from $20 while keeping a Hold stance
- First-quarter 2026 earnings per share reached $0.13, significantly exceeding the $0.03 projection
- First-quarter sales totaled $4.7 billion, surpassing the $4.61 billion expectation
- UBS maintains a Sell recommendation with a $9.00 target, expressing concerns about competitive positioning
Macy’s shares have experienced impressive momentum recently, culminating in a fresh 52-week peak of $25.67 per share on Wednesday, representing an increase of approximately 1.84% during trading.
The upward movement followed TD Cowen’s decision to increase its price objective from $20 to $25. While maintaining its Hold recommendation, the firm highlighted enhanced execution in product selection and brand portfolio as catalysts for the revision. Shares initially spiked 3.9% following the announcement before moderating to approximately $24.87.
This fresh analyst focus emerged after an impressive first-quarter 2026 performance. Macy’s delivered earnings per share of $0.13 — dramatically exceeding the $0.03 analyst consensus. Sales reached $4.7 billion, topping the $4.61 billion forecast. Comparable store sales increased 3% during the first quarter, more than doubling the projected 1.4% gain.
Bloomingdale’s played a significant role in the quarter’s success. The upscale division achieved 10.2% comparable sales growth in Q1, substantially outperforming the flagship Macy’s brand and bolstering consolidated results.
Analyst Community Shows Divergent Views
Not all market watchers share the optimistic outlook. UBS continues to hold a Sell rating with a $9.00 price objective — representing a substantial discount to current trading levels. The firm’s concerns focus on sustained market share challenges, a persistent issue facing traditional department store retailers.
InvestingPro data introduces additional complexity: despite robust price performance, the platform indicates the stock trades above its calculated fair value. The price-to-earnings multiple stands at 10.43, which appears reasonable, but the extraordinary 138.66% one-year total return has elevated the stock into potentially overextended territory according to certain valuation frameworks.
That one-year performance figure deserves emphasis. Shareholders who held positions twelve months ago have witnessed their investments more than double in value.
Broader Market Conditions Provided Support
The stock received additional momentum from macroeconomic developments. In early June, equity markets rallied after President Trump reversed plans for military strikes against Iran, canceling proposed operations following productive diplomatic discussions. The S&P 500 advanced 1.4% and the Nasdaq climbed 1.8% during that session, with Macy’s surging 6.8% on that particular day.
Macy’s has demonstrated significant volatility throughout the year — the stock has experienced single-day moves exceeding 5% on twenty different occasions during the past twelve months.
For the current year, shares have advanced 9.3%. As a reference point, an investment of $1,000 in Macy’s five years ago would have grown to approximately $1,279 today.
The stock currently trades near its 52-week peak of $25.66, with the retailer receiving a financial health score of 3.12 out of 5 from InvestingPro.


